Tram Bui
Vice President of Investor Relations and Corporate Communications
Replay available
Halozyme Therapeutics, Inc. (HALO) Q3 2025 Earnings Call
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Q3 2025 earnings conference call, held 2025-11-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Helen Torley
President and Chief Executive Officer
Nicole Labrosse
Chief Financial Officer
Sean Lehman
Analyst, Morgan Stanley
Jason Butler
Analyst, Citizens JMP
Michael DeFiore
Analyst, Evercore ISI
Mitchell Kapoor
Analyst, HCW
Brendan Smith
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Halozyme Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.736 Simply press star, then the number one on your telephone keypad. 00:00:04.736 -- 00:00:07.238 Please note, this event is being recorded. 00:00:07.238 -- 00:00:12.263 I will now turn the call over to Tram Bui, Halazim's 00:00:12.263 -- 00:00:16.628 Vice President of Investor Relations and Corporate Communications. 00:00:16.628 -- 00:00:17.589 Please go ahead. 00:00:17.589 -- 00:00:19.070 Thank 00:00:19.070 -- 00:00:24.636 you, operator. Good afternoon, and welcome to our third quarter 2025 Financial 00:00:24.636 -- 00:00:29.513 and Operating Results Conference call. In addition to the press release issued today 00:00:29.513 -- 00:00:34.318 after the market closed, you could find a supplementary slide presentation that will 00:00:34.318 -- 00:00:40.105 be referenced during today's call in the investor relations section of our website. 00:00:40.105 -- 00:00:44.471 Leading the call will be Dr. Helen Torley, HALA Science President and Chief Executive 00:00:44.471 -- 00:00:49.957 Officer, who will provide an update on our business, and Nicole Labrosse, our Chief Financial 00:00:49.957 -- 00:00:54.571 Officer, will review our financial results as well as our outlook. 00:00:54.571 -- 00:00:59.257 On today's call, we will be making forward-looking statements as outlined on slide two. 00:00:59.257 -- 00:01:04.344 I would also refer you to our SEC filings for a full list of risks and 00:01:04.344 -- 00:01:05.866 uncertainties. 00:01:05.866 -- 00:01:10.392 During the call, both GAAP and non-GAAP financial measures will be discussed. 00:01:10.392 -- 00:01:15.178 Certain non-GAAP or adjusted financial measures are reconciled with the comparable GAAP 00:01:15.178 -- 00:01:18.963 financial measures in our earnings press release and slide presentat...